Establishment of new bio-substance safety and efficacy screening center eyed

Published: 2003-12-19 06:57:00

Updated: 2003-12-19 06:57:00

The Korea Food and Drug Administration said on December 15 that the establishment of a new substance safety and efficacy screening center is being soon promoted within its toxicology research institute, as such a screening center is a must for consolidating and expanding Korea's infrastructure fo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK